CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for CareDx Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

CareDx Inc
8000 Marina Blvd, 4Th Floor
Phone: (415) 287-2300p:415 287-2300 BRISBANE, CA  94005  United States Ticker: CDNACDNA
Business Summary
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. Its commercially available testing services consist of AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The Company’s product portfolio includes AlloSeq Tx, QTYPE, Olerup SSP, AlloSeq HCT and AlloSeq cfDNA. It develops and provides diagnostic surveillance testing services for various transplant recipients.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes--Yes

Industries
SIC Code Description
8071 Medical laboratories
2834 Pharmaceutical preparations
7372 Prepackaged software

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Michael D.Goldberg 66 11/1/2021 11/1/2011
President, Chief Executive Officer, Director John W.Hanna 44 4/15/2024 4/15/2024
Chief Financial Officer AbhishekJain 48 4/15/2024 5/26/2022
7 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Allenex AB Franzngatan 5 Stockholm Sweden
CareDx Transplant Management Inc PO Box 913368 Denver CO
CareDx Transplant Management Inc PO Box 913368 Denver CO USA
4 additional Subsidiary records available in full report.

Business Names
Business Name
Allenex AB
BFS Molecular S.R.L.
CareDx AB
12 additional Business Names available in full report.

General Information
Number of Employees: 635 (As of 12/31/2023)
Outstanding Shares: 53,633,871 (As of 10/31/2024)
Shareholders: 63
Stock Exchange: NASD
Federal Tax Id: 943316839
Fax Number: (302) 636-5454


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024